Clonal and chronological genetic analysis of multifocal cancers of the bladder and upper urinary tract

Cancer Research

Volumn 58, Issue 24, 1998, Pages 5835-5841

  Takahashi, Takeshi ^a   Habuchi, Tomonori ^a   Kakehi, Yoshiyuki ^a   Mitsumori, Kenji ^a   Akao, Toshiya ^a   Terachi, Toshiro ^a   Yoshida, Osamu ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ARTICLE; BLADDER CANCER; CHROMOSOME DELETION; CLINICAL ARTICLE; GENETIC ANALYSIS; GENETIC VARIABILITY; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; INTRAVESICAL DRUG ADMINISTRATION; PRIORITY JOURNAL; STEM CELL; URINARY TRACT CANCER;

CHROMOSOME ABERRATIONS; CLONE CELLS; GENETIC HETEROGENEITY; HUMANS; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; NEOPLASMS, MULTIPLE PRIMARY; STEM CELLS; URINARY BLADDER NEOPLASMS; UROLOGIC NEOPLASMS;

EID: 0032535274     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Messing, E. M., and Catalona, W. Urothelial tumors of the urinary tract. In: Campbell's Urology, Ed. 5, Vol. 3, pp. 2327-2410. New York: W. B. Saunders, 1997.
2. Jones, P. A., and Droller, M. J. Pathways of development and progression in bladder cancer: new correlations between clinical observations and molecular mechanisms. Semin. Urol., 11: 177-192, 1993.
3. Prout, G. R., Jr., Barton, B. A., Griffin, P. P., and Friedell, G. H. Treated history of noninvasive grade 1 transitional cell carcinoma. The National Bladder Cancer Group. J. Urol., 148: 1413-1419, 1992.
4. Heney, N. M., Daly, J., Prout, G. R., Jr., Nieh, P. T., Heaney, J. A., and Trebeck, N. E. Biopsy of apparently normal urothelium in patients with bladder carcinoma. J. Urol., 120: 559-560, 1978.
5. Soloway, M. S., Jordan, A. M., and Murphy, W. M. Rationale for intravesical chemotherapy in the treatment and prophylaxis of superficial transitional cell carcinoma. Prog. Clin. Biol. Res., 310: 215-236, 1989.
6. Kakizoe, T., Fujita, J., Murase, T., Matsumoto, K., and Kishi, K. Transitional cell carcinoma of the bladder in patients with renal pelvic and ureteral cancer. J. Urol., 124: 17-19, 1980.
7. Amar, A. D., and Das, S. Upper urinary tract transitional cell carcinoma in patients with bladder carcinoma and associated vesicoureteral reflux. J. Urol., 133: 468-471, 1985.
8. Sidransky, D., Frost, P., von Eschenbach, A., Oyasu, R., Preisinger, A. C., and Vogelstein, B. Clonal origin of bladder cancer. N. Engl. J. Med., 326: 737-740, 1992.
9. Habuchi, T., Takahashi, R., Yamada, H., Kakehi, Y., Sugiyama, T., and Yoshida, O. Metachronous multifocal development of urothelial cancers by intraluminal seeding. Lancet, 342: 1087-1088, 1993.
10. Miyao, N., Tsai, Y. C., Lerner, S. P., Olumi, A. F., Spruck, C. H., III, Gonzalez Zulueta, M., Nichols, P. W., Skinner, D. G., and Jones, P. A. Role of chromosome 9 in human bladder cancer. Cancer Res., 53: 4066-4070, 1993.
11. Vogelstein, B., Fearon, E. R., Kern, S. E., Hamilton, S. R., Preisinger, A. C., Nakamura, Y., and White, R. Allelotype of colorectal carcinomas. Science (Washington DC), 244: 207-211, 1989.
12. Nawroz, H., van der Riet, P., Hruban, R. H., Koch, W., Ruppert, J. M., and Sidransky, D. Allelotype of head and neck squamous cell carcinoma. Cancer Res.,54: 1152-1155, 1994.
13. Sato, T., Tanigami, A., Yamakawa, K., Akiyama, F., Kasumi, F., Sakamoto, G., and Nakamura, Y. Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer. Cancer Res.,50: 7184-7189, 1990.
14. Sato, S., Nakamura, Y., and Tsuchiya, E. Difference of allelotype between squamous cell carcinoma and adenocarcinoma of the lung. Cancer Res.,54: 5652-5655, 1994.
15. Schneider, B. G., Pulitzer, D. R., Brown, R. D., Prihoda, T. J., Bostwick, D. G., Saldivar, V., Rodriguez Martinez, H. A., Gutierrez Diaz, M. E., and O'Connell, P. Allelic imbalance in gastric cancer: an affected site on chromosome arm 3p. Genes Chromosomes Cancer, 13: 263-271, 1995.
16. Jones, M. H., Koi, S., Fujimoto, I., Hasumi, K., Kato, K., and Nakamura, Y. Allelotype of uterine cancer by analysis of RFLP and microsatellite polymorphisms: frequent loss of heterozygosity on chromosome arms 3p, 9q, 10q, and 17p. Genes Chromosomes Cancer, 9: 119-123, 1994.
17. Fujimori, M., Tokino, T., Hino, O., Kitagawa, T., Imamura, T., Okamoto, E., Mitsunobu, M., Ishikawa, T., Nakagama, H., Harada, H., Yagura, M., Matsubara, K., and Nakamura, Y. Allelotype study of primary hepatocellular carcinoma. Cancer Res.,51: 89-93, 1991.
18. Sidransky, D., Mikkelsen, T., Schwechheimer, K., Rosenblum, M. L., Cavanee, W., and Vogelstein, B. Clonal expansion of p53 mutant cells is associated with brain tumour progression. Nature (Lond.), 355: 846-847, 1992.
19. Knowles, M. A., Elder, P. A., Williamson, M., Cairns, J. P., Shaw, M. E., and Law, M. G. Allelotype of human bladder cancer. Cancer Res.,54: 531-538, 1994.
20. Dalbagni, G., Presti, J., Reuter, V., Fair, W. R., and Cordon Cardo, C. Genetic alterations in bladder cancer. Lancet, 342: 469-471, 1993.
21. Habuchi, T., Ogawa, O., Kakehi, Y., Ogura, K., Koshiba, M., Hamazaki, S., Takahashi, R., Sugiyama, T., and Yoshida, O. Accumulated allelic losses in the development of invasive urothelial cancer. Int. J. Cancer.,53: 579-584, 1993.